AI-powered platform for cancer patients called Mika assists people affected by cancer over the course of their disease and therapy
Fosanis has raised €10M across 1 funding round from 4 investors, most recently a Series A round in May 2022. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-09 | Series A | €10M |
| Ananda Impact Ventures,Debiopharm Innovation Fund,Equity Pitcher ,Ship2B Ventures |
| View deal → |
